Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis
NCT ID: NCT02493166
Last Updated: 2016-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2016-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Because the lesions are spread in the brains, there is a variety of symptoms. The most common symptom is the typical motor dysfunction. 66% of persons with MS, and even 81% of them after 15 years, have problems with movements in one or both upper extremities.
Also, 40 untill 70% of persons with Multiple Sclerosis have cognitive impairment. Although they are less visible, they can have a major determining influence on social or work-related domains. The most frequent cognitive dysfunctions are sustained attention, reduced speed of information processing, impaired memory and limited executive functions.
When a combination, of motor and cognitive task, is asked, the execution of these tasks could be difficult with the foregoing in mind. For example problems during chatting while cooking, typing a report at a meeting or watching television while ironing.
The dual-task paradigm assumes that the attention should be divided between two simultaneous tasks. A dual task cost (DTC) is a restriction in performance on each task, compared whit the separate task versus simultaneously.
Research on dual tasking with persons with MS has already studied extensively, but not specific on the upper limb. In 2015 Learmonth, Pilutti and Motl published an primary research on the DTC. They combined the movements of the upper limb with a cognitive task. The research showed a difference between Persons with MS and the control group. At methodological level, there is lacking on the randomization of tasks. That is an important bias because of the learning effect of the tasks. They used only one task for the upper limb; this isn't enough to generalize the concept of motor interference in Persons with MS.
The study has two research questions:
* Have Persons with MS a greater DTC compared with a healthy control group? The motor task is executed with the upper limb.
* Is there a difference on DTC in persons with MS depending on the motor task?
This research is an observational case-control study in which individuals with MS will be compared to a healthy control group. They will be two moments of assessments. On the first day the general performance of the persons will be measured, by using clinical evaluation tests and questionnaires. On the second day they will be tests on the dual tasks, specific a comparison between single versus simultaneously performed tasks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychometric Properties Upper Limb Function Measures Multiple Sclerosis
NCT02339675
Effects of A Dual-Task Intervention in Postural Control in Multiple Sclerosis Patients
NCT04090996
Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis
NCT02398149
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis
NCT04619953
Resting Postural Tremor in Multiple Sclerosis
NCT04405479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with Multiple sclerosis Dual task cost
Dual task cost (cognitive-motor interference), comparing single versus dual task performance (on both motor and cognitive task)
dual task cost (cognitive-motor interference)
comparing single versus dual task performance (on both motor and cognitive task)
Healthy volontiers Dual task cost
Dual task cost (cognitive-motor interference), comparing single versus dual task performance (on both motor and cognitive task)
dual task cost (cognitive-motor interference)
comparing single versus dual task performance (on both motor and cognitive task)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dual task cost (cognitive-motor interference)
comparing single versus dual task performance (on both motor and cognitive task)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+
* Have no other neurological or orthopedic disorder of the upper limb or spine. They should have the possibility to actively participate in the research.
* Nine hole peg test, in which the cut-off value is set at 0.5 PEG / sec
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AZ Klina
OTHER
University Hospital, Antwerp
OTHER
private practice physician De Barsy
UNKNOWN
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Feys
prof. dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Feys, prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Joke Raats
Role: STUDY_CHAIR
AZ Klina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Klina
Brasschaat, , Belgium
Private practice physician De Barsy
Brasschaat, , Belgium
Hasselt University
Diepenbeek, , Belgium
UZ Antwerp
Edegem, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-PFE-JRA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.